Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function.

J Clin Invest 2007 Apr 22;117(4):1058-67. Epub 2007 Mar 22.

Endocrinology Unit, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom.

Prenatal stress or glucocorticoid administration has persisting "programming" effects on offspring in rodents and other model species. Multiple doses of glucocorticoids are in widespread use in obstetric practice. To examine the clinical relevance of glucocorticoid programming, we gave 50, 120, or 200 microg/kg/d of dexamethasone (dex50, dex120, or dex200) orally from mid-term to a singleton-bearing nonhuman primate, Chlorocebus aethiops (African vervet). Dexamethasone dose-dependently reduced maternal cortisol levels without effecting maternal blood pressure, glucose, electrolytes, or weight gain. Birth weight was unaffected by any dexamethasone dose, although postnatal growth was attenuated after dex120 and dex200. At 8 months of age, dex120 and dex200 offspring showed impaired glucose tolerance and hyperinsulinemia, with reduced (approximately 25%) pancreatic beta cell number at 12 months. Dex120 and dex200 offspring had increased systolic and diastolic blood pressures at 12 months. Mild stress produced an exaggerated cortisol response in dex200 offspring, implying hypothalamic-pituitary-adrenal axis programming. The data are compatible with the extrapolation of the glucocorticoid programming hypothesis to primates and indicate that repeated glucocorticoid therapy and perhaps chronic stress in humans may have long-term effects.

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI30982DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821070PMC
April 2007
1 Read

Publication Analysis

Top Keywords

dex120 dex200
16
dex200 offspring
12
glucocorticoid programming
8
hypothalamic-pituitary-adrenal axis
8
nonhuman primate
8
offspring
5
dex200
5
unaffected dexamethasone
4
dexamethasone dose
4
glucose tolerance
4
birth weight
4
gain birth
4
tolerance hyperinsulinemia
4
dose postnatal
4
weight unaffected
4
growth attenuated
4
months age
4
age dex120
4
impaired glucose
4
dex200 months
4

References

(Supplied by CrossRef)

Barker et al.
Clin. Sci. 1998

Barker et al.
Ann. Intern. Med. 1999

Hales et al.
Diabetologia. 1992

Curhan et al.
Circulation. 1996

Rich-Edwards et al.
BMJ. 2005

Edwards et al.
Lancet. 1993

Levitt et al.
Neuroendocrinology. 1996

Nyirenda et al.
J. Endocrinol. 2001

O’Regan et al.
Am. J. Physiol. Endocrinol. Metab. 2004

Shen et al.
Biochem. J. 2003

Welberg et al.
Eur. J. Neurosci. 2000

Similar Publications